🇺🇸 Dihydroxydibutylether group in United States

Dihydroxydibutylether group (Dihydroxydibutylether group) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Dihydroxydibutylether group in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Dihydroxydibutylether group approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Dihydroxydibutylether group in United States?

Pusan National University Yangsan Hospital is the originator. The local marketing authorisation holder may differ — check the official source linked above.